{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:53:10Z","timestamp":1772754790574,"version":"3.50.1"},"reference-count":63,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Neuroblastoma, a paediatric malignancy of the peripheral nervous system, displays a wide range of clinical outcomes, including regression to fatality despite extensive treatment. Neuroblastoma tumours display a complex interplay with their surrounding environment, known as the tumour microenvironment, which may affect disease progression and patient prognosis. This study aimed to dissect the ways in which neuroblastoma biology, treatment, prognosis, progression, and relapse are linked with the extracellular matrix, the dichotomous identities of neuroblastoma, various regulatory proteins and RNA, and extracellular vesicles within the backdrop of the tumour microenvironment. In addition, other aspects, such as immune cell infiltration, therapeutic options including monoclonal antibodies and small molecule inhibitors; and the ways in which these may affect disease progression and immunosuppression within the context of the neuroblastoma tumour microenvironment, are addressed. Such studies may shed light on useful therapeutic targets within the tumour microenvironment that may benefit groups of NB patients. Ultimately, a detailed understanding of these aspects will enable the neuroblastoma scientific community to improve treatment options, patient outcomes, and quality of life.<\/jats:p>","DOI":"10.3390\/curroncol30100659","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:31:22Z","timestamp":1697419882000},"page":"9116-9140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-8447","authenticated-orcid":false,"given":"Leila","family":"Jahangiri","sequence":"first","affiliation":[{"name":"School of Science and Technology, Nottingham Trent University, Clifton Site, Nottingham NG11 8NS, UK"},{"name":"Division of Cellular and Molecular Pathology, Addenbrookes Hospital, University of Cambridge, Cambridge CB2 0QQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hoc.2009.11.011","article-title":"Neuroblastoma: Biology, Prognosis, and Treatment","volume":"24","author":"Park","year":"2010","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: Biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpedsurg.2018.09.004","article-title":"Update on neuroblastoma","volume":"54","author":"Newman","year":"2019","journal-title":"J. Pediatr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-017-2747-0","article-title":"Neuroblastoma pathogenesis: Deregulation of embryonic neural crest development","volume":"372","author":"Tomolonis","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-021-00818-x","article-title":"Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin","volume":"53","author":"Kameneva","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41417-023-00599-x","article-title":"\u03b23-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-\u03b3-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma","volume":"30","author":"Bruno","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised Neuroblastoma Risk Classification System: A Report from the Children\u2019s Oncology Group","volume":"39","author":"Irwin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_11","first-page":"CD010774","article-title":"Rapid COJEC versus standard induction therapies for high-risk neuroblastoma","volume":"5","author":"Peinemann","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.30050","article-title":"The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma","volume":"139","author":"Bogen","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/med.21750","article-title":"Molecular targeting therapies for neuroblastoma: Progress and challenges","volume":"41","author":"Zafar","year":"2021","journal-title":"Med. Res. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/onco2020007","article-title":"Profiling of the Prognostic Role of Extracellular Matrix-Related Genes in Neuroblastoma Using Databases and Integrated Bioinformatics","volume":"2","author":"Jahangiri","year":"2022","journal-title":"Onco"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_18","first-page":"693","article-title":"Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview","volume":"27","author":"Noguera","year":"2012","journal-title":"Histol. Histopathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/s41467-023-38239-5","article-title":"Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma","volume":"14","author":"Thirant","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.34133\/research.0033","article-title":"PTBP2-Mediated Alternative Splicing of IRF9 Controls Tumor-Associated Monocyte\/Macrophage Chemotaxis and Repolarization in Neuroblastoma Progression","volume":"6","author":"Tang","year":"2023","journal-title":"Research"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41388-023-02671-0","article-title":"IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis","volume":"42","author":"Dhamdhere","year":"2023","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.xcrm.2022.100657","article-title":"The immune cell atlas of human neuroblastoma","volume":"3","author":"Verhoeven","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111455","DOI":"10.1016\/j.celrep.2022.111455","article-title":"Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory","volume":"41","author":"Yuan","year":"2022","journal-title":"Cell Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jahangiri, L., and Ishola, T. (2022). Exosomes in Neuroblastoma Biology, Diagnosis, and Treatment. Life, 12.","DOI":"10.3390\/life12111714"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A., Gagliani, C., Tacchetti, C., Mauri, P., Melioli, G., and Pistoia, V. (2013). Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075054"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1597614","DOI":"10.1080\/20013078.2019.1597614","article-title":"Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: Implications of intra-tumour heterogeneity","volume":"8","author":"Fonseka","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sauvage, D., Bosseler, M., Viry, E., Kanli, G., Oudin, A., Berchem, G., Keunen, O., and Janji, B. (2022). The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model. Cells, 11.","DOI":"10.3390\/cells11182783"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ol.2023.13883","article-title":"Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma","volume":"26","author":"Zhang","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.4769","article-title":"Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development","volume":"240","author":"Hashimoto","year":"2016","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e004807","DOI":"10.1136\/jitc-2022-004807","article-title":"Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma","volume":"10","author":"Costa","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2022.03.012","article-title":"Immune contexture of paediatric cancers","volume":"170","author":"Franz","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/10935266211039200","article-title":"Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination","volume":"25","author":"Truong","year":"2022","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-9-35","article-title":"Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression","volume":"9","author":"Lam","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bui, C.-B., To, K.D., Vu, D.M., Nguyen, Q.-G., Nguyen, H.T., and Nguyen, S.-B. (2023). Denatured collagen inhibits neuroblastoma tumor-sphere migration and growth via the LOX\/LOXL2\u2014FAK signaling pathway. J. Therm. Biol., 115.","DOI":"10.1016\/j.jtherbio.2023.103624"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13046-020-01729-1","article-title":"Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line","volume":"39","author":"Monferrer","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ng.3899","article-title":"Neuroblastoma is composed of two super-enhancer-associated differentiation states","volume":"49","author":"Koster","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41467-019-09470-w","article-title":"A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma","volume":"10","author":"Akogul","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jahangiri, L., Tsaprouni, L., Trigg, R.M., Williams, J.A., Gkoutos, G.V., Turner, S.D., and Pereira, J. (2020). Core regulatory circuitries in defining cancer cell identity across the malignant spectrum. Open Biol., 10.","DOI":"10.1098\/rsob.200121"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12672-021-00452-3","article-title":"Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors","volume":"12","author":"Jahangiri","year":"2021","journal-title":"Discov. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13046-022-02523-x","article-title":"B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met\/AKT\/mTOR\/IRF-1 axis in neuroblastoma","volume":"41","author":"Sha","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Jahangiri, L. (2023). Metastasis in Neuroblastoma and Its Link to Autophagy. Life, 13.","DOI":"10.3390\/life13030818"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Jahangiri, L., and Ishola, T. (2022). Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095271"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12326","DOI":"10.1002\/jev2.12326","article-title":"The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche","volume":"12","author":"Blavier","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1183720","DOI":"10.3389\/fphar.2023.1183720","article-title":"The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment","volume":"14","author":"Proestler","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2184130","DOI":"10.1080\/2162402X.2023.2184130","article-title":"Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy","volume":"12","author":"Valind","year":"2023","journal-title":"Oncoimmunology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1073\/pnas.87.15.5613","article-title":"Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms\/CSF-1 receptor cDNA","volume":"87","author":"Pierce","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(20)30023-1","article-title":"Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): A multicentre, open-label, single-arm, phase 1\u20132 trial","volume":"21","author":"Davis","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jss.2023.03.042","article-title":"CD69 on Tumor-Infiltrating Cells Correlates with Neuroblastoma Suppression by Simultaneous PD-1 and PD-L1 Blockade","volume":"289","author":"Inoue","year":"2023","journal-title":"J. Surg. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1179559X17719106","DOI":"10.1177\/1179559X17719106","article-title":"Dinutuximab in the Treatment of High-Risk Neuroblastoma in Children","volume":"9","author":"Gur","year":"2017","journal-title":"Clin. Med. Insights Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1039\/D2SC05749B","article-title":"Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma","volume":"14","author":"Mills","year":"2023","journal-title":"Chem. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"713158","DOI":"10.3389\/fimmu.2021.713158","article-title":"Leveraging NKG2D Ligands in Immuno-Oncology","volume":"12","author":"Fuertes","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/1078-0432.CCR-22-0717","article-title":"Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma","volume":"28","author":"Nguyen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e005881","DOI":"10.1136\/jitc-2022-005881","article-title":"Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma","volume":"11","author":"Sun","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3390\/cimb45040218","article-title":"The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin","volume":"45","author":"Correia","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1116995","article-title":"Tissue cells feel and respond to the stiffness of their substrate","volume":"310","author":"Discher","year":"2005","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.matbio.2019.07.006","article-title":"Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling","volume":"85\u201386","author":"Berger","year":"2020","journal-title":"Matrix Biol."},{"key":"ref_57","first-page":"e62627","article-title":"Three-dimensional In Vitro Biomimetic Model of Neuroblastoma using Collagen-based Scaffolds","volume":"173","author":"Gallagher","year":"2021","journal-title":"J. Vis. Exp."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/ng.3921","article-title":"Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries","volume":"49","author":"Boeva","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2004.09.011","article-title":"TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma","volume":"6","author":"Tacconelli","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e002417","DOI":"10.1136\/jitc-2021-002417","article-title":"Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma","volume":"9","author":"Bao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e004399","DOI":"10.1136\/jitc-2021-004399","article-title":"Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1148317","DOI":"10.3389\/fimmu.2023.1148317","article-title":"Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma","volume":"14","author":"Rohila","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7946021","DOI":"10.1155\/2018\/7946021","article-title":"Secretory High-Mobility Group Box 1 Protein Affects Regulatory T Cell Differentiation in Neuroblastoma Microenvironment In Vitro","volume":"2018","author":"Vanichapol","year":"2018","journal-title":"J. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/10\/659\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:07:16Z","timestamp":1760130436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/10\/659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["curroncol30100659"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30100659","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}